Exousia Bio (LMMY) Return on Equity (2023 - 2025)

Exousia Bio has disclosed Return on Equity across 3 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.0%, up 4.0% year-over-year; the trailing twelve-month figure through Nov 2025 was 0.0% (up 4.0% YoY), and the FY2024 annual result was 0.01%, down 3.0% from the prior year.
• Return on Equity came in at 0.0% for Q4 2025 at Exousia Bio, up from 0.04% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.02% in Q2 2023 to a low of 0.04% in Q4 2024.
• The 3-year median for Return on Equity is 0.01% (2024), against an average of 0.0%.
• Across the five-year window, Return on Equity fell 5 bps in 2024 and advanced 4 bps in 2025, its largest moves.
• Exousia Bio's Return on Equity stood at 0.01% in 2023, then slumped by 430 bps to 0.04% in 2024, then jumped by 100 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.04% (Q4 2024), and 0.0% (Q3 2024), per Business Quant data.